SHAREHOLDERS' DEFICIT - Schedule of Stockholders Equity (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Increase (Decrease) in Stockholders' Equity
Shareholders' equity, beginning balance	$ (4,162,172)	$ (1,243,986)
Net loss	(3,279)	(71,974)
Other comprehensive income	607	1,895
Compensation related to share-based awards	11,240	4,929
Tax withholding for restricted shares		(1,863)
Other	(1)	1
Shareholders' equity, ending balance	(4,153,605)	(1,310,998)
Euro Deferred Shares
Increase (Decrease) in Stockholders' Equity
Shareholders' equity, beginning balance	43	45
Other		(1)
Shareholders' equity, ending balance	43	44
Ordinary Shares
Increase (Decrease) in Stockholders' Equity
Shareholders' equity, beginning balance	24	23
Other		1
Shareholders' equity, ending balance	24	24
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity
Shareholders' equity, beginning balance	8,969,322	8,953,906
Compensation related to share-based awards	11,240	4,929
Tax withholding for restricted shares		(1,863)
Other	(1)	1
Shareholders' equity, ending balance	8,980,561	8,956,973
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity
Shareholders' equity, beginning balance	(12,904,620)	(9,981,515)
Net loss	(3,279)	(71,974)
Shareholders' equity, ending balance	(12,907,899)	(10,053,489)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity
Shareholders' equity, beginning balance	(226,941)	(216,445)
Other comprehensive income	607	1,895
Shareholders' equity, ending balance	$ (226,334)	$ (214,550)